Akebia Therapeutics | AKBA - Les Intérêts Débiteurs Sur La Dette





Les Intérêts Débiteurs Sur La Dette Changement Date
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Akebia Therapeutics 349.66M 12.86M 2026-06
Alnylam Pharmaceuticals USD 82.05M 12.76M 2026-06
Amgen USD 95.64B 94.98B 2026-06
Ardelyx USD 5.6M 160K 2026-03
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 340M 144M 2026-06
Bayer EUR 675M 87M 2025-12
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Celltrion KRW 19B 1.96B 2025-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Exelixis USD 23.4M 3.9M 2023-09
Fresenius Medical Care EUR 83M 4M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
J&J USD 43M 25M 2026-03
Kangmei Pharma CNY 1.82M 150K 2025-09
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Medical Developments International AUD 18K 3K 2025-06
Moderna USD 10.96B 527M 2026-06
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Neuren Pharmaceuticals AUD 0 0 2024-06
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pharma Mar EUR 117K 1.24M 2025-09
Prothena USD 302.58M 47.32M 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Qiagen NV USD 10.02M 1.03M 2026-06
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Vanda Pharmaceuticals -1.37B 1.97B 2025-12
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06